Arcutis Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Westlake Village, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Arcutis Biotherapeutics, Inc. has filed 834 SEC EDGAR filings since 09 Sep 2019

SEC filing history

Showing 676-700 of 834 matching filings.

Per page
25
Current page
28
4

FORM 4

Filing date
03 Mar 2021
Reporting date
01 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2021
Reporting date
01 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2021
Reporting date
01 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2021
Reporting date
01 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2021
Reporting date
01 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Feb 2021
Reporting date
22 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Feb 2021
Reporting date
16 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-253155

S-8

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2021
Reporting date
10 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91349

AMENDMENT NO. 2 TO SCHEDULE 13D

Filing date
09 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91349

AMENDMENT NO. 2

Filing date
09 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91349

SC 13D/A

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Feb 2021
Reporting date
05 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Feb 2021
Reporting date
04 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91349

SC 13G/A filing

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-252612

424B5

Filing date
04 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Feb 2021
Reporting date
29 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .